5家港股IPO获中国证监会备案

Core Viewpoint - Five companies have received approval from the China Securities Regulatory Commission (CSRC) for their H-share IPOs in Hong Kong, indicating a growing trend of Chinese companies seeking international capital markets [1]. Group 1: Company Listings - The companies approved for H-share listings include: - Luoshi (Shandong) Robot Group Co., Ltd. plans to issue up to 30,499,700 shares [4]. - Nanjing Yingpai Pharmaceutical Co., Ltd. plans to issue up to 89,771,800 shares [10]. - Shanghai Xizhi Technology Co., Ltd. plans to issue up to 15,864,495 shares [16]. - Yunyinggu Technology Co., Ltd. plans to issue up to 76,086,600 shares [22]. - Zhejiang Dongfang Kemai Electronics Co., Ltd. plans to issue up to 9,348,900 shares [28]. Group 2: Share Conversion - Luoshi (Shandong) Robot Group will convert 226,759,580 shares from domestic unlisted to overseas listed shares [4]. - Nanjing Yingpai Pharmaceutical will convert 234,188,130 shares from domestic unlisted to overseas listed shares [10]. - Shanghai Xizhi Technology will convert 60,986,081 shares from domestic unlisted to overseas listed shares [16]. - Yunyinggu Technology will convert 374,919,750 shares from domestic unlisted to overseas listed shares [22]. - Zhejiang Dongfang Kemai Electronics will convert 46,067,139 shares from domestic unlisted to overseas listed shares [28]. Group 3: Regulatory Compliance - Each company must report any significant events to the CSRC during the period from the issuance of the approval until the completion of the overseas listing [4][10][16][22][28]. - Companies are required to submit a report on the issuance and listing status within 15 working days after the completion of the overseas listing [4][10][16][22][28].